| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |